Bio-Techne Corporation
TECH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $8 | $9 | $11 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9 | $8 | $10 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.6% | 0.2% | 6.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 66.4% | 62.7% | 67.9% | 65.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 27.1% | 2% | 21.5% | 24.3% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 13.3% | -5.6% | 7.1% | 11.7% |
| EPS Diluted | 0.24 | -0.11 | 0.14 | 0.22 |
| % Growth | 318.2% | -178.6% | -36.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |